Review



systems mab3381 10  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems systems mab3381 10
    Systems Mab3381 10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/systems+mab3381+10/Human%2FMouse%2FRat+Activin+A+beta+A+subunit+Antibody/pm40419762-329-13-12
    Average 93 stars, based on 24 article reviews
    systems mab3381 10 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Mouse Assay:

    Article Title: Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia
    Article Snippet: Mice aged 10–14 weeks were treated systemically with anti-activin A neutralizing antibody (R&D systems, MAB3381; 10 mg kg −1 body weight) 1 week after tumor implantation through the tail vein every 4 days.

    Article Title: Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexia.
    Article Snippet: Mice aged 10–14 weeks were treated systemically with anti-activin A neutralizing antibody (R&D systems, MAB3381; 10 mg kg−1 body weight) 1 week after tumor implantation through the tail vein every 4 days.

    Tumor Implantation:

    Article Title: Skeletal muscle endothelial dysfunction through the activin A–PGC1α axis drives progression of cancer cachexia
    Article Snippet: Mice aged 10–14 weeks were treated systemically with anti-activin A neutralizing antibody (R&D systems, MAB3381; 10 mg kg −1 body weight) 1 week after tumor implantation through the tail vein every 4 days.

    Article Title: Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexia.
    Article Snippet: Mice aged 10–14 weeks were treated systemically with anti-activin A neutralizing antibody (R&D systems, MAB3381; 10 mg kg−1 body weight) 1 week after tumor implantation through the tail vein every 4 days.



    Similar Products

    93
    R&D Systems systems mab3381 10
    Systems Mab3381 10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/systems+mab3381+10/Human%2FMouse%2FRat+Activin+A+beta+A+subunit+Antibody/pm40419762-329-13-12
    Average 93 stars, based on 1 article reviews
    systems mab3381 10 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results